SPYRE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.51 USD | -2.63% |
|
-6.42% | +46.42% |
| May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
| May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-06-11 | 2024-06-12 | 2024-06-13 | 2024-06-14 | |
|---|---|---|---|---|
| Last | 37.98 $ | 37 $ | 32.36 $ | 31.51 $ |
| Volume | 459 780 | 426 289 | 797 308 | 791 185 |
| Change | +4.08% | -2.58% | -12.54% | -2.63% |
| Opening | 36.04 | 38.51 | 36.77 | 31.78 |
| High | 38.22 | 38.90 | 36.77 | 32.60 |
| Low | 35.14 | 36.81 | 30.99 | 30.74 |
Performance
| 1 day | -2.63% | ||
| 1 week | -6.42% | ||
| Current month | -9.84% | ||
| 1 month | -19.80% | ||
| 3 months | -24.83% | ||
| 6 months | +112.33% | ||
| Current year | +46.42% | ||
| 1 year | +769.24% | ||
| 3 years | -80.87% | ||
| 5 years | -79.61% |
Volumes
marketsDaily volume
791 185
Estimated daily volume
791 185
Avg. Volume 20 sessions
382 280
Daily volume ratio
2.07
Avg. Volume 20 sessions USD
12 045 642.80
Record volume 1
10 228 381
Record volume 2
3 156 959
Record volume 3
2 233 298
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
1 600 152 919
Net sales (USD)
886 000
Number of employees
30
Sales / Employee (USD)
29 533
Free-Float
91.03 %
Free-Float capitalization (USD)
1 456 626 634
Average Daily Capital Traded
0.75%
Highs and lows
1 week
30.74
38.90
1 month
30.7438.90
Current year
18.5447.97
1 year
2.6647.97
3 years
2.66212.50
5 years
2.66284.50
10 years
2.66318.75
Indicators
Moving average 5 days
35.07
Moving average 20 days
35.10
Moving average 50 days
35.39
Moving average 100 days
33.31
Price spread / (MMA5)
+11.29%
Price spread / (MMA20)
+11.41%
Price spread / (MMA50)
+12.33%
Price spread / (MMA100)
+5.72%
STIM
RSI 9 days
39.77
RSI 14 days
42.92
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -2.63% | -6.42% | +46.42% | +769.24% | 1.6B | ||
| +0.35% | -0.48% | +18.15% | +40.99% | 124B | ||
| +0.97% | +3.35% | +18.02% | +34.42% | 112B | ||
| +0.64% | +1.78% | +5.07% | -0.91% | 22.94B | ||
| -4.08% | -8.23% | -12.75% | -17.01% | 22.22B | ||
| -2.28% | +3.98% | -9.86% | -21.88% | 17.02B | ||
| +0.47% | -5.05% | -14.97% | -31.24% | 16.88B | ||
| -2.89% | +3.09% | -39.94% | -35.41% | 16.87B | ||
| -0.59% | +0.36% | +2.80% | +43.76% | 13.63B | ||
| -1.73% | -0.39% | +27.39% | -5.81% | 11.61B | ||
| +3.72% | +12.44% | +106.26% | +231.36% | 10.31B | ||
| -1.45% | +2.78% | +16.15% | +39.20% | 7.94B | ||
| -2.79% | -6.85% | -29.45% | -38.45% | 7.74B | ||
| -0.13% | +3.79% | -2.04% | +21.55% | 7.57B | ||
| -0.16% | -6.95% | +1.34% | +41.24% | 7.32B | ||
| -1.00% | -0.64% | -9.38% | +15.76% | 6.33B | ||
| Average | -0.85% | -0.22% | +7.70% | +67.93% | ||
| Weighted average by Cap. | -0.10% | +0.66% | +10.76% | +28.98% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
541810fa2c.acNPusz8rfoZcKN3lNGASr8nuTWBSC_YaZ-rYoppKGA.NqAi04Cx_6lXN8oV_aDJG81N7WXVBH26ANWfFtkIGhoBphzym76UsC4U6g
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 31.51 | 13,386 | 591,788 |
| 03:59:59 pm | 31.51 | 100 | 578,402 |
| 03:59:59 pm | 31.5 | 200 | 578,302 |
| 03:59:59 pm | 31.51 | 100 | 578,102 |
| 03:59:59 pm | 31.5 | 168 | 578,002 |
| 03:59:58 pm | 31.51 | 100 | 577,834 |
| 03:59:56 pm | 31.51 | 100 | 577,734 |
| 03:59:55 pm | 31.51 | 261 | 577,634 |
| 03:59:52 pm | 31.5 | 468 | 577,373 |
| 03:59:52 pm | 31.5 | 101 | 576,905 |
Monthly variations
Annual change
| 2024 | +46.42% | ||
| 2023 | +91.33% | ||
| 2022 | -90.53% | ||
| 2021 | -39.64% | ||
| 2020 | +3.01% | ||
| 2019 | +2.00% | ||
| 2018 | +38.45% | ||
| 2017 | +24.37% | ||
| 2016 | -63.72% |
- Stock Market
- Equities
- SYRE Stock
- Quotes Spyre Therapeutics, Inc.
